CAMBRIDGE, Mass. (AP) - Aveo Oncology said Wednesday that the Food and Drug Administration will complete a review of its cancer pill Tivopath by July 28.
Aveo and its partner Astellas Pharma Inc. want to market Tivopath as a treatment for advanced kidney cancer. The companies said the FDA accepted their application, and the agency will conduct a standard 10-month review. Astellas will pay Aveo $15 million now that the filing has been accepted.
Tivopath, or tivozanib, is a tablet intended to be taken once per day. The companies are also studying the drug as a treatment for other solid tumors, including cancers of the breast and colon.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Butler County and Wayne County, Indiana remain under a level one snow emergency Saturday afternoon.
Hauer Music has found a new home in Centerville, as the Dayton Metro Library prepares to move into Hauer's downtown location.
A Springfield woman was injured after she lost control of her vehicle and hit a utility pole on U.S. 40 in Clark County.
The all-clear has been given at Springfield Regional Medical Center, after a bomb threat forced a search of the hospital early Saturday morning.
Two people were arrested early Saturday morning after leading police on a slow speed pursuit with a stolen snow plow.